Dr. Schell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-5534
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1978 - 1979
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1977 - 1978
New York Medical College at St Michael's Medical CenterResidency, Internal Medicine, 1975 - 1977- New York Medical College at St Michael's Medical CenterInternship, Internal Medicine, 1974 - 1975
Rutgers New Jersey Medical SchoolClass of 1974
Certifications & Licensure
NH State Medical License 1998 - 2018
VT State Medical License 1999 - 2016
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- 26 citationsBisantrene, an active new drug in the treatment of metastatic breast cancer.Hwee-Yong Yap, Boh-Seng Yap, George R. Blumenschein, Brian C. Barnes, Frank C. Schell
Cancer Research. 1983-03-01 - 178 citationsMultimodal treatment of locoregionally advanced breast cancer.Gabriel N. Hortobagyi, George R. Blumenschein, William J. Spanos, Eleanor D. Montague, Aman U Buzdar
Cancer. 1983-03-01 - 58 citationsManagement of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens.Aman U Buzdar, Sewa S. Legha, Gabriel N. Hortobagyi, Hwee-Yong Yap, Charles L. Wiseman
Cancer. 1981-06-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
